NASDAQ:BIOA BioAge Labs Q3 2025 Earnings Results & Report $5.65 -0.22 (-3.75%) Closing price 04:00 PM EasternExtended Trading$5.70 +0.05 (+0.88%) As of 04:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. BioAge Labs beat analyst earnings expectations in its Q3 2025 results, released November 6, 2025. The company reported EPS of -$0.56 versus the -$0.67 consensus estimate, while revenue was $2.05 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2025Report DateNovember 6, 2025TimeAfter Market ClosesConference Call4:00 PM ET BioAge Labs EPS ResultsActual EPS-$0.56Consensus EPS -$0.67Beat/MissBeat by +$0.11One Year Ago EPSN/AEPS Beat Rate4 of last 6 quartersBioAge Labs Revenue ResultsActual Revenue$2.05 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsEarnings Release(8-K)Quarterly Report(10-Q) BioAge Labs Q3 2025 Earnings FAQ Did BioAge Labs beat earnings estimates for Q3 2025? BioAge Labs (NASDAQ:BIOA) reported earnings of -$0.56 per share for Q3 2025, beating the consensus estimate of -$0.67. The report was announced on Thursday, November 6, 2025. What was BioAge Labs' revenue for Q3 2025? BioAge Labs reported revenue of $2.05 million for Q3 2025. BioAge Labs Earnings HeadlinesBTIG Research Reaffirms Buy Rating for BioAge Labs (NASDAQ:BIOA)November 11 at 2:07 AM | americanbankingnews.comBioAge Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 6, 2026 | marketscreener.comMMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a household name. Now he says a similar shift is unfolding in AI infrastructure. Hundreds of billions are pouring into AI data centers, but he warns the builders could get crushed by their own costs while one overlooked sector absorbs the spending.November 12 at 1:00 AM | Porter & Company (Ad)BioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business UpdatesNovember 5, 2026 | globenewswire.comHead-To-Head Contrast: InMed Pharmaceuticals (NASDAQ:INM) versus BioAge Labs (NASDAQ:BIOA)November 5, 2026 | americanbankingnews.comDeep Origin Announces Multi-Target Ai-Driven Drug Discovery Collaboration with BioAge Labs, IncOctober 14, 2026 | marketscreener.comMSee More BioAge Labs Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like BioAge Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioAge Labs and other key companies, straight to your email. Email Address About BioAge LabsBioAge Labs (NASDAQ:BIOA) is a clinical-stage biopharmaceutical company developing medicines for metabolic diseases by targeting biological pathways associated with aging. Its research platform draws on human data to identify age-related mechanisms that may be relevant to disease and treatment. The company’s pipeline includes BGE-102, an investigational oral inhibitor of the NLRP3 protein, which is being developed for metabolic conditions. BioAge previously studied azelaprag, an apelin-receptor agonist, but discontinued its development after safety concerns arose in a clinical trial. Founded in 2015, BioAge is headquartered in Richmond, California. Co-founder Kristen Fortney, Ph.D., serves as the company’s chief executive officer.View BioAge Labs ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping3 Pharmaceutical Stocks That Offer Safety and GrowthKeeping AI Cool: AAON Rides the AI Heatwave to Record GrowthPalantir’s Real Washington Risk Isn’t the Budget—It’s OversightCoreWeave's Backlog Is Surging—Can the Stock Follow?Can Constellation Energy's Contracts Power a Stock Rebound? Upcoming Earnings Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
